| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in PTCT over the last quarter tilts toward selling: insiders offloaded a net 122,370 shares worth roughly $8.5M. In the past 30 days, 0 insiders bought and 2 sold. The bias lately has been to the sell side.
All 2 insiders who sold still hold shares after their sales. Classified under Biotechnology (Health Care sector), PTCT's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.29M | $77.68M | -5,000 | |
| CEO | 383.9K | $26.32M | - | |
| VP | 105.3K | $6.76M | -2,265 | |
| CFO | 84.0K | $6.75M | - | |
| VP | 79.1K | $5.38M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 14, 2026 | Schmertzler Michael | Director | Sell10b5-1 | 2,500 | $59.61 | $149,036.84 | -0.2% | - | - | |
| Oct 9, 2026 | Boulding Mark Elliott55 | Executive VP and CLO | Sale+OE10b5-1 | 192 | $64.26 | $12,337.92 | -0.2% | - | - | |
| Oct 7, 2026 | Schmertzler Michael | Director | Sell10b5-1 | 2,500 | $63.39 | $158,480.21 | -0.2% | - | - | |
| Oct 6, 2026 | Boulding Mark Elliott55 | Executive VP and CLO | Sale+OE10b5-1 | 2,073 | $64.06 | $132,790.74 | -1.9% | - | - | |
| Sep 30, 2026 | Steele Glenn Jr Md Phd | Director | Sale+OE10b5-1 | 12,000 | $65.16 | $781,920.00 | -34.8% | - | - | |
| Sep 17, 2026 | Schmertzler Michael | Director | Sell10b5-1 | 20,000 | $67.49 | $1,349,727.74 | -1.5% | - | - | |
| Sep 10, 2026 | Schmertzler Michael | Director | Sell10b5-1 | 20,000 | $67.59 | $1,351,803.36 | -1.5% | - | - | |
| Aug 27, 2026 | Schmertzler Michael | Director | Sell10b5-1 | 25,000 | $72.26 | $1,806,509.14 | -1.8% | - | - | |
| Aug 20, 2026 | Schmertzler Michael | Director | Sell10b5-1 | 25,000 | $72.22 | $1,805,411.39 | -1.8% | - | - | |
| Aug 17, 2026 | Boulding Mark Elliott55 | Executive VP and CLO | Sale+OE10b5-1 | 2,813 | $72.57 | $204,127.26 | -2.6% | - | - |